Eromona Whiskey Selected Research

Agranulocytosis (Granulocytopenia)

1/2022	Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis.
5/2019	Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis.
10/2017	The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
8/2017	Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
11/2015	Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
9/2012	Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report.
1/2007	Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eromona Whiskey Research Topics

Disease

15	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2005
15	Treatment-Resistant Schizophrenia 01/2022 - 01/2007
12	Neutropenia 01/2022 - 01/2007
7	Agranulocytosis (Granulocytopenia) 01/2022 - 01/2007
4	Schizophrenia (Dementia Praecox) 04/2022 - 01/2019
2	Sialorrhea 01/2022 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2021 - 02/2009
2	Myocarditis (Carditis) 01/2020 - 12/2019
2	Cardiotoxicity 12/2019 - 12/2017
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Vitamin D Deficiency 12/2021
1	Drug-Related Side Effects and Adverse Reactions 10/2021
1	Sepsis (Septicemia) 01/2020
1	Obesity 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	COVID-19 01/2020
1	Infections 01/2020
1	Heart Failure 01/2020
1	Fever (Fevers) 01/2020
1	Pancreatitis 01/2020
1	Chest Pain (Chest Pains) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2019
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2013
1	Leukocytosis (Pleocytosis) 01/2007

Drug/Important Bio-Agent (IBA)

29	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 01/2007
9	Antipsychotic Agents (Antipsychotics)IBA 04/2022 - 01/2005
5	Pharmaceutical PreparationsIBA 01/2020 - 02/2011
3	Vitamin D FDA LinkGeneric 12/2021 - 01/2020
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2017 - 11/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2013
2	Scopolamine (Hyoscine)FDA Link 05/2019 - 01/2019
2	LithiumIBA 11/2015 - 01/2007
1	Penfluridol (Semap)IBA 01/2022
1	VortioxetineIBA 01/2022
1	cariprazineIBA 01/2022
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 12/2021
1	boldenone undecylenate (Equipoise)IBA 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 01/2020
1	AntigensIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Olanzapine (Zyprexa)FDA Link 05/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 05/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2017
1	CytokinesIBA 08/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2015
1	metylperon (melperone)IBA 02/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2007
2	Drug Therapy (Chemotherapy) 04/2022 - 01/2007
2	Withholding Treatment 01/2020 - 01/2007
1	Contraindications 12/2021
1	Long-Term Care 08/2020